logo
ProjectCompleted

Goodlife Pharma

Sector: Government • Location: Kenya

Source: International Finance Corporation (IFC)

The project involves a proposed $4.5 million loan by IFC to finance expansion activity and potential acquisitions by Goodlife, a company established by Africa Chemist & Beauty Care Inc. (“ACBC”) to be the leading branded pharmacy chain in East Africa. Goodlife presently consists of 5 recently acquired pharmacy stores operating under the brand name Mimosa in multiple locations in Kenya. Over the ne

Status
Closed
Sector
Government, Hospital
Location
Kenya
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Goodlife Pharma

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Goodlife Pharma” is an infrastructure initiative in the Government sector, located in Kenya. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

The project involves a proposed $4.5 million loan by IFC to finance expansion activity and potential acquisitions by Goodlife, a company established by Africa Chemist & Beauty Care Inc. (“ACBC”) to be the leading branded pharmacy chain in East Africa. Goodlife presently consists of 5 recently acquired pharmacy stores operating under the brand name Mimosa in multiple locations in Kenya. Over the next 5 years, Goodlife aims to rebrand these stores and acquire and establish new stores to create the leading branded pharmacy chain in East Africa.

Original sector

G-FA - Pharmaceuticals and Medicine

Location

Country

Kenya

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Government, Hospital

Article published date

2025-09-10

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project